FormulaOne
We specialize in formulation development of injectable peptides and proteins tailored for first human use.
We specialize in formulation development of injectable peptides and proteins tailored for first human use.
Discovery and development of novel antibiotics to treat multidrug-resistant infections.
Specialized in fusion molecules based on secondary metabolites from eukaryotes.
Developing game-changing alternatives to fossil-based plastics
Develops enzyme-powered topical products for improved management of skin conditions
formerly known as Arxx Therapeutics, develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis